|
2012 Speakers Included:
After finishing his study Chemical Engineering, Ronald started working in formulation development in the pharmaceutical industry. For Solvay Pharmaceuticals (now Abbott) he worked at a manufactur... [ view bio ]
Robin is an engineer from the Eindhoven University of Technology, holding a master in Process Engineering from the Chemical Engineering faculty. He has experience both in complex molecular system... [ view bio ]
Karl Box is the Chemistry R&D Manager at Sirius and one of the inventors of the CheqSol method for solubility measurement. He has been with Sirius since 1993 and is an expert in the field of ... [ view bio ]
Dr. Bi is a Technical Director – Solubility at Ashland Specialty Ingredients. She has held various positions in Pfizer Global RD, Vertex Pharmaceuticals and AstraZeneca Pharmaceuticals befo... [ view bio ]
... [ view bio ]
Keith Horspool is the Vice President of Pharmaceutical Development at Boehringer-Ingelheim, Ridgefield, CT. His department encompasses physical pharmaceutics, formulation development, and process... [ view bio ]
Val has industry leading expertise in drug design and development across a broad range of new chemical entities, parenteral and oral dosage forms, from Research to Global Registration, for both H... [ view bio ]
Ralph Lipp is Vice President - Pharmaceutical Sciences Research and Development at Eli Lilly and Company in Indianapolis, Indiana, USA. His main areas of focus are preformulation, enabling formul... [ view bio ]
Mr. Heltovics holds Master's degrees in Biology (1995), Chemistry (1995), and Business Administration (MBA - 2003). In 1995 he won an annual postgraduate research scholarship at Oxford University... [ view bio ]
Dr. Beth Hill
Head, Drug Delivery & Device Development; Sr Director, Biologics Delivery
Johnson & Johnson
Head, Drug Delivery & Device Development; Sr Director, Biologics Delivery
Johnson & Johnson
Beth is responsible for end to end support of the drug delivery and device development needs of J&J Pharma. This scope includes: partnerships with Discovery to identify enabling technologies ... [ view bio ]
CEO of XSpray since September 2006 Dr. Andersson has more than 10 years of successful executive management experience in research, development and commercial operations. XSpray’s proprieta... [ view bio ]
Kelly S. Kraft studied medicinal chemistry at the University of Georgia in Athens, GA (USA). After earning her PhD, she spent several years at Emisphere Technologies where she designed and synth... [ view bio ]
Senior Research Fellow at Johnson and Johnson Consumer Healthcare Division, NJ, US. Mandar is currently managing Topical Group and used to manage EyeCare Group at J&J. Mandar received his P... [ view bio ]
Todd Hein is the Sr. Director of Life Sciences focused on the pharmaceutical, medical device, biotechnology, and nutritional industries at Oracle. Core responsibilities are to share best practice... [ view bio ]
Dr Norbert Rasenack
Team Lead, Downstream Solids, Continuous Manufacturing Unit, Global Pharmaceutical Development/Technical R&D
Novartis Pharma AG
Team Lead, Downstream Solids, Continuous Manufacturing Unit, Global Pharmaceutical Development/Technical R&D
Novartis Pharma AG
Norbert is a Pharmacist by education, holding a PhD in Pharmaceutical Technology from the University of Kiel. He has worked for several years in different pharmaceutical companies in technical re... [ view bio ]
Dr. Dieter Becker studied Pharmacy at the University of Freiburg in Germany and got his licensure as Pharmacist in 1984. He finished 1988 his thesis in pharmaceutical technology at the Univers... [ view bio ]
Marcus E. Brewster is a Distinguished Research Fellow at Janssen Research and Development (The Pharmaceutical Companies of Johnson & Johnson) based in Beerse, Belgium. He is a member of the ... [ view bio ]
In his current position in global marketing new excipients at BASF SE, Germany, Andreas is supporting BASF’s activities in hot-melt extrusion technology. Andreas’ expertise is mainly... [ view bio ]
Dirk Pamperin currently functions as Vice President, R&D at Synthon and has done so since 2005. In this role, he is responsible for research and development of the Synthon group with 160 rese... [ view bio ]
Astrid Franken studied chemistry. She started her career in 2002 at Hemoteq AG, a German coating services provider, where she worked on various research and development projects in the field of d... [ view bio ]
Jerry Parker
Former Associate Director, Global Pharmaceutical and Analytical Sciences (Retired)
Abbott Laboratories
Former Associate Director, Global Pharmaceutical and Analytical Sciences (Retired)
Abbott Laboratories
Jerry Parker is recently-retired Director, Pharmaceutical Development within Abbott’s Global Pharmaceutical Research and Development division. In his most recent role, he was responsible fo... [ view bio ]
Andrew has 17 years experience in the life science industry, with the last 12 years focused on product/platform development in the area of combination products. Currently, Andrew is the Senior D... [ view bio ]
Delphine is Head of Pharmaceutical Applications at Gattefossé in St Priest France. The Applications Laboratory develops and characterizes oral, topical and rectal dosage forms. For o... [ view bio ]
Karin Liltorp is a Physical Chemist by education, holding a PhD in Biophysics from the University of Roskilde. During her Ph.D, her major focus was on the interaction between proteins and water/... [ view bio ]
Sven Stegemann is a pharmacist by training and holds a PhD in pharmacology. He started his career at Sanofi-Aventis working in different roles of the pharmaceutical product development and manufa... [ view bio ]
Following his medical studies and graduation at the Pitié-Salpétrière Hospital , Philippe Guillet specialized in Geriatrics and Gerontology and practiced for about 10 years at the ... [ view bio ]
Prof Andreas Zimmer
Senior Research Head, Pharmaceutical Technology, Nanotechnology, Drug Delivery & Biotechnology
University of Graz
Austria
Senior Research Head, Pharmaceutical Technology, Nanotechnology, Drug Delivery & Biotechnology
University of Graz
Austria
Dr William van’t Hoff
Co-Director, National Institute for Health Medicines for Children Research Network
NHS
Co-Director, National Institute for Health Medicines for Children Research Network
NHS
William van’t Hoff is a Consultant Paediatric Nephrologist at Great Ormond Street Hospital for Children NHS Trust. He obtained his BSc (Hons) in Clinical Pharmacology & Therapeutics fro... [ view bio ]
Nigel Fox is a Senior Pharmaceutical Assessor at the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). He studied Pharmacy at the University of Aston in Birmingham and firs... [ view bio ]
Dr Catherine Tuleu
Director
Centre for Paediatric Pharmacy Research
& Senior Lecturer, Pharmaceutics (Paediatic Drug Delivery)
The School of Pharmacy, University of London
UK
Director
Centre for Paediatric Pharmacy Research
& Senior Lecturer, Pharmaceutics (Paediatic Drug Delivery)
The School of Pharmacy, University of London
UK
Dr Catherine Tuleu is a UK-qualified French pharmacist. She graduated from Université Paris V and obtained her PhD with distinction from Université Paris XI. After a postdoctoral period... [ view bio ]
After finishing his PhD in chemistry at ETH Zurich dealing with bio-polymeric drug release systems, Dr. Christof Böhler moved to the United States for a Postdoc at the Salk and Scripps Resea... [ view bio ]
In 2005 Yves Duccini was appointed Global Research and Development Director for SEPPIC (100% subsidiary of AIR LIQUIDE) working essentially in the health and beauty applications (pharmacy, food,... [ view bio ]
Jan Jezek, the principal inventor of the core protein stabilisation technologies, is a biochemist with a strong background in physical chemistry. Jan is currently responsible for R&D activiti... [ view bio ]
Professor Josef Thalhamer
Associate Director, Research
Biomay AG
& Vice Director, Department of Molecular Biology
Salzburg University
Associate Director, Research
Biomay AG
& Vice Director, Department of Molecular Biology
Salzburg University
Josef Thalhamer studied biochemistry and then focused on immunochemical/immunological topics. In the past 15 years, he dealt with DNA vaccines against malaria, borreliosis and type I allergy. Rec... [ view bio ]
Howard is Emeritus Research Professor of Drug Delivery at the Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde, Glasgow. He has been principal research supervisor o... [ view bio ]
Jeff Mazzeo
Late Stage Development Director, Pharmaceutical and Life Science Business Operations
Waters Corporation
Late Stage Development Director, Pharmaceutical and Life Science Business Operations
Waters Corporation
Jeff received his Ph.D. from Northeastern University in 1992, working under the direction of Professor Ira Krull. His thesis title was “EOF Driven Capillary Isoelectric Focusing: Developmen... [ view bio ]
Robert is a pharmacist from the Swiss Federal School of Technology. After 8 years in formulations development at Cilag with exposure to numerous interfaces within Johnson & Johnson he became ... [ view bio ]
Christian is a chemist who obtained his PhD from the University of Basel. As a grad student he synthesized and characterized short water-insoluble peptides with the ability to self-emulsify to dr... [ view bio ]
Tejash Shah is a Formulation Scientist at GlaxoSmithKline Biopharm R&D unit in Stevenage, Hertfordshire, UK. He is a qualified Pharmacist with wide range experience in Drug Discovery & De... [ view bio ]
Michel is a medical biologist by training and received his Ph.D. in molecular virology from the University of Amsterdam, The Netherlands. He also holds an MBA from Rotterdam School of Management,... [ view bio ]
Markus is a pharmacist from Heidelberg University with a PhD focusing on the effect of excipients on GIT absorption investigated in cell culture models. During 4 years in product development at R... [ view bio ]
Dr. Thomas Dürig serves as Director of Pharmaceutical Research and Development at Ashland Specialty Ingredients. Based at the Ashland Research Center in Wilmington, DE, he leads global rese... [ view bio ]
David McManus is currently a Lead Consultant within the Global Professional Services organisation at IDBS and supports presales and deployment of IDBS E-WorkBook Suite. David gained a MChem in ... [ view bio ]
Dr. Fehring joined Silence Therapeutics AG (Berlin) in November 2007. Prior to that he was Project Director and Lab Head at Capsulution Nanosience AG and Celares GmbH (Berlin, 2001-2007), where h... [ view bio ]
2011 Speakers Included:
With drug development process costing more with every year there is a clear need to change earlier philosophy of fast to man. Candidates were rushed into development with fingers crossed hoping ... [ view bio ]
Dr Joel Richard
Senior Director, Head of Drug Product Development, Pharmaceutical Development
Ipsen
France
Senior Director, Head of Drug Product Development, Pharmaceutical Development
Ipsen
France
Injectable long-acting protein therapeutics appear as one of the most attractive new dosage forms that biotech companies have been trying to develop for the last 10 years. The significant interes... [ view bio ]
A significant proportion of drugs on the market are poorly soluble in water and it is expected that this will be even more pronounced in the future. Formulations of poorly water-soluble compounds... [ view bio ]
The manufacturing of protein drugs involves the use of several operational processing steps often referred to as “unit operations” where the protein is subjected to a variety of stres... [ view bio ]
Continuous Manufacturing Technologies enable harvesting opportunities in pharmaceutical production, but also within Pharmaceutical Development and Clinical Trial Medication Manufacture. “U... [ view bio ]
Combination products are gaining increasing importance as companies look at ways to deliver an increasing number of peptide and protein drugs as well as improving ease of use for patients. Parent... [ view bio ]
The bioavailability of poorly water-soluble drugs can be increased by using semi solid formulation with mixtures of , for instance, esters of long fatty acids (gelucire, PEG etc.). Ho... [ view bio ]
Elise Titulaer-Jacobs
Head Analytical Product Support
Abbott Healthcare Products B.V.
The Netherlands
Head Analytical Product Support
Abbott Healthcare Products B.V.
The Netherlands
During her position as a production manager, Elise Titulaer-Jacobs experienced the benefits of operational excellence and lean six sigma techniques. With this knowledge she returned to R&D se... [ view bio ]
Karsten Petersson received his PhD degree form The Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark with focus on the influence of physicochemical properties and formulation ... [ view bio ]
Dr George Shlieout
Head of Drug Form Development and Production Head of IMP
Abbott Products GmbH
Germany
Head of Drug Form Development and Production Head of IMP
Abbott Products GmbH
Germany
Using the solid dosage form is very often to design formulations of NCEs, whereas such design is not common when purified proteins are used as APIs. In this study the challenges faced by using t... [ view bio ]
Computational oral absorption simulation is anticipated to be a powerful tool in drug research. In this presentation, fully mechanistic simulation of oral absorption will be discussed, explicitly... [ view bio ]
Dr. Jörg Knäblein identifies and evaluates technologies, projects, molecules, or companies for in-licensing or purchasing. Before he had several managerial positions within the company,... [ view bio ]
Pharmacist and Ph.D. in pharmaceutical technology, Gregory Lambert starts his career as a researcher, with a focus on nanotechnologies applied to drug delivery. He is author of 25 international r... [ view bio ]
Mondher Toumi is M.D., M.Sc. in Biological Sciences and Ph.D. in Economic Sciences. After having worked in the laboratory of pharmacology at the University of Marseille, Mondher Toumi joined the ... [ view bio ]
Prof Kumar and his group aim to harness the full therapeutic potential of existing drug molecules by devising new ways of making them reach and act at the target site in the body. His research ad... [ view bio ]
James Mann is a Analytical Chemist, obtaining his Masters in Science from the University of Strathclyde in 2002 which included an industrial placement year with GSK in Pharmaceutical Development.... [ view bio ]
As Managing Partner in SR One (GSK Corporate Venture Fund), David Phillips leads SR One’s investment activities as well as pioneering a new function to incubate and spin-out technologies fr... [ view bio ]
Formulators and the formulation development process are critical in the drug development process. Formulators need to assimilate data from a wide variety of sources across many functional areas a... [ view bio ]
Most compounds that enter drug development are lipophilic and sparingly water soluble. Poorly soluble drugs generally have low dissolution velocity and exhibit a small concentration gradient acro... [ view bio ]
Microfluidics Reaction Technology (MRT) is a continuous processing technology used to produce nanomaterials “bottom up” through crystallization, precipitation and chemical reactions ... [ view bio ]
Dr Timothy Bee
Senior Director, Global Pharmaceuticals Technical
International Specialty Products (ISP)
USA
Senior Director, Global Pharmaceuticals Technical
International Specialty Products (ISP)
USA
With the increasing trends in outsourcing by both large and small pharmaceutical companies, it is not only important to find CROs that have the right technical capabilities, but it is also import... [ view bio ]
Continuous manufacturing is growing to a hype in pharma secondary manufacturing as it can contribute importantly to the sustainability of the industry. The continuous processing of tablets, powde... [ view bio ]
WuXi AppTec, listed on the New York Stock Exchange is the largest CRO in China. It was incorporated in Dec 2000 and started offering FTE based services for Chemistry. Over the years WuXi has broa... [ view bio ]
Dr. Eric Carlson joined Freeslate as the VP of Marketing and Solution Development in March 2010 and is now serving as the VP of Collaborations & Solution Development. Before joining Freeslate... [ view bio ]
Facebook
